NRSCF
NOMURA HOLDINGS INC
$8.45
0.00%
No data for this timeframe.
Vol
SEC Reports4
Exchange OTC·Sector Security Brokers, Dealers & Flotation Companies·Inc. M0·CIK 0001163653·Prev Close $8.45
Recent Activity
Jun 9, 2026
SEC
Nomura Holdings filed a Form 6-K furnishing materials related to its 122nd Annual General Meeting of Shareholders, inclu
6-K — Impact 2/10
May 29, 2026
SEC
Nomura Holdings filed its Notice of Convocation for the 122nd Annual General Meeting of Shareholders (Form 6-K). This is
6-K — Impact 2/10
Apr 15, 2026
SEC
Nomura Holdings completed a share buyback of 14.3 million shares for 18.5 billion yen between April 1 and April 15, 2026
6-K — Impact 4/10
Analyst Ratings
1Strong Buy
7Buy
6Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
2/10
Nomura Holdings filed a Form 6-K furnishing materials related to its 122nd Annual General Meeting of Shareholders, inclu
Jun 9, 2026
NEUTRAL
6-K
2/10
Nomura Holdings filed its Notice of Convocation for the 122nd Annual General Meeting of Shareholders (Form 6-K). This is
May 29, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.0/10.
NEUTRAL
6-K
2/10
Nomura Holdings filed a Form 6-K furnishing materials related to its 122nd Annual General Meeting of
Jun 9, 2026
NEUTRAL
6-K
2/10
Nomura Holdings filed its Notice of Convocation for the 122nd Annual General Meeting of Shareholders
May 29, 2026
NEUTRAL
6-K
4/10
Nomura Holdings completed a share buyback of 14.3 million shares for 18.5 billion yen between April
Apr 15, 2026
NEUTRAL
6-K
4/10
Nomura Holdings announced the status of its ongoing share buyback program, repurchasing 24.6 million
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 57% buy across 14 analysts — 1 strong buy, 7 buy, 6 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $560.2B | 7.0% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $549.6B | 6.6% | — |
| Current FY 2027-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $2193.3B | 1.2% | — |
| Next FY 2028-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $2230.9B | 1.7% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 7 | 6 | 0 | 0 | 57% | |
| May 1, 2026 | 1 | 7 | 6 | 0 | 0 | 57% | |
| Apr 1, 2026 | 1 | 7 | 5 | 0 | 0 | 62% | |
| Mar 1, 2026 | 1 | 6 | 6 | 0 | 0 | 54% | |
| Feb 1, 2026 | 1 | 6 | 6 | 0 | 0 | 54% | |
| Jan 1, 2026 | 1 | 6 | 5 | 0 | 0 | 58% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.